Athanor Capital’s Abiomed Inc ABMD Stock Holding History

Athanor Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,270	Closed	-$629K	–	845
2020 Q3	$629K	Buy	+2,270	New	+$654K	0.02%	298

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Athanor Capital's ABMD Position: Q4 2020 in Review

Athanor Capital sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 2,270 shares — an estimated $629K sold.

Athanor Capital first reported a position in ABMD in Q3 2020 and held it in 1 quarter. The position peaked at $629K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

Athanor Capital reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
Athanor Capital sold 2,270 Abiomed Inc shares in Q4 2020, an estimated $629K.
Athanor Capital first reported a position in Abiomed Inc in Q3 2020 and held it in 1 quarter.
Athanor Capital's Abiomed Inc position peaked at $629K in Q3 2020.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.